RxDoctor Payments Data

Joseph McGowan, MD

MOHS-Micrographic Surgery · Bluffton, SCNPI 1548341340

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,880 of the $10,198 with a category attached, or 87.1%. Acera Surgical, Inc. accounts for 95.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $9,265 and has fallen 99.4% since, to $57 in 2025.

$10,198in general payments, 2019–2025

Across 26 payments — averaging $392.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$10K
  • Genentech USA, Inc.$143
  • Dermira, Inc.$97
  • Regeneron Healthcare Solutions, Inc.$75
  • Hydrofera LLC$50
  • Mayne Pharma Commercial LLC$36
  • plus $80 from 5 others

What the payments were for

  • Consulting fees$8,88087%
  • Food & beverage$1,01910%
  • Education$2993%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,198 in reported general payments places this provider in the 85th percentile of 22 mohs-micrographic surgery providers in South Carolina.

See all mohs-micrographic surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$653,731
Medicare patients
644
Services billed
2,065

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin288$2,070
Gentamicin Sulfate54$1,732
Cephalexin323$1,118
Ketoconazole40$566
Doxycycline Hyclate40$286
Azithromycin15$100
ValacyclovirValacyclovir Hcl12$97
Tramadol Hcl34$50

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Bluffton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →